Literature DB >> 17656647

Lymphoma dissemination: the other face of lymphocyte homing.

Steven T Pals1, David J J de Gorter, Marcel Spaargaren.   

Abstract

The orchestration of systemic immune responses is critically dependent on coordinated lymphocyte migration and recirculation. This "homing" guides lymphocytes to the microenvironments that control their differentiation and survival, disperses the immunologic repertoire, and targets effector lymphocytes to sites of antigenic insult. Lymphocyte homing is a multistep process that requires chemotaxis and cell adhesion coupled with strategies to overcome physical barriers. At the molecular level, it is regulated by adhesion molecules and chemokines, and facilitated by intrinsic molecular programs that allow "ameboid" shape change, allowing highly effective lymphocyte traffic between different tissue compartments. In case of malignant transformation, however, the fact that lymphocytes are "licensed to move" forms a serious threat to the organism, because it permits rapid tumor dissemination irrespective of the conventional anatomic boundaries limiting early spread in most types of cancer. Thus, unlike the metastatic spread of other cancers, lymphoma dissemination generally is not a reflection of tumor progression but of conserved physiological behavior. The dissemination patterns often reflect basic rules of lymphocyte homing, explaining the strikingly tissue-specific dissemination of, for example, mucosal lymphomas, cutaneous lymphomas, and multiple myeloma. Understanding the molecular mechanisms underlying this behavior may provide novel targets for treatment of lymphoma patients.

Entities:  

Mesh:

Year:  2007        PMID: 17656647     DOI: 10.1182/blood-2007-05-075176

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  47 in total

Review 1.  Central role of paxillin phosphorylation in regulation of LFA-1 integrins activity and lymphocyte migration.

Authors:  Larisa Y Romanova; J Frederic Mushinski
Journal:  Cell Adh Migr       Date:  2011 Nov-Dec       Impact factor: 3.405

Review 2.  Tissue-specific homing of immune cells in malignant skin tumors.

Authors:  Hajnalka Jókai; Márta Marschalkó; Judit Csomor; József Szakonyi; Orsolya Kontár; Gábor Barna; Sarolta Kárpáti; Péter Holló
Journal:  Pathol Oncol Res       Date:  2012-04-24       Impact factor: 3.201

3.  Natural history of CNS relapse in patients with aggressive non-Hodgkin's lymphoma: a 20-year follow-up analysis of SWOG 8516 -- the Southwest Oncology Group.

Authors:  Steven H Bernstein; Joseph M Unger; Michael Leblanc; Jonathan Friedberg; Thomas P Miller; Richard I Fisher
Journal:  J Clin Oncol       Date:  2008-12-01       Impact factor: 44.544

4.  Clinical significance of co-expression of CD21 and LFA-1 in B-cell lymphoma.

Authors:  Kazushi Tanimoto; Yoshihiro Yakushijin; Hiroshi Fujiwara; Masaki Otsuka; Koichi Ohshima; Atsuro Sugita; Akira Sakai; Takaaki Hato; Hitoshi Hasegawa; Masaki Yasukawa
Journal:  Int J Hematol       Date:  2009-04-11       Impact factor: 2.490

5.  High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphoma.

Authors:  W Kraan; M van Keimpema; H M Horlings; E J M Schilder-Tol; M E C M Oud; L A Noorduyn; P M Kluin; M J Kersten; M Spaargaren; S T Pals
Journal:  Leukemia       Date:  2013-11-20       Impact factor: 11.528

6.  Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas.

Authors:  Aadra P Bhatt; Prasanna M Bhende; Sang-Hoon Sin; Debasmita Roy; Dirk P Dittmer; Blossom Damania
Journal:  Blood       Date:  2010-03-18       Impact factor: 22.113

7.  Unexpected dissemination patterns in lymphoma progression revealed by serial imaging within a murine lymph node.

Authors:  Ken Ito; Bryan Ronain Smith; Natesh Parashurama; Joon-Kee Yoon; Si Yeol Song; Cornelius Miething; Parag Mallick; Scott Lowe; Sanjiv Sam Gambhir
Journal:  Cancer Res       Date:  2012-10-02       Impact factor: 12.701

Review 8.  Immunologic Milieu of Mature T-Cell and NK-Cell Lymphomas-Implications for Therapy.

Authors:  Eric Tse; Yok-Lam Kwong
Journal:  Curr Hematol Malig Rep       Date:  2018-02       Impact factor: 3.952

9.  The dangers of déjà vu: memory B cells as the cells of origin of ABC-DLBCLs.

Authors:  Leandro Venturutti; Ari M Melnick
Journal:  Blood       Date:  2020-11-12       Impact factor: 22.113

10.  18F-labeled anti-human CD20 cys-diabody for same-day immunoPET in a model of aggressive B cell lymphoma in human CD20 transgenic mice.

Authors:  Kirstin A Zettlitz; Richard Tavaré; Wen-Ting K Tsai; Reiko E Yamada; Noel S Ha; Jeffrey Collins; R Michael van Dam; John M Timmerman; Anna M Wu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-11-19       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.